[Imidazole receptors and blood pressure regulation. High receptor selectivity of moxonidine].
Molderings
G J
GJ
Institut für Pharmakologie und Toxikologie, Universität Bonn.
Göthert
M
M
Christen
O
O
Schäfer
S G
SG
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects*; D002415:Cats; D003000:Clonidine / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007093:Imidazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010080:Oxazoles / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D000077769:Rilmenidine
D000316:Adrenergic alpha-Agonists; D000959:Antihypertensive Agents; D007093:Imidazoles; D010080:Oxazoles; D011955:Receptors, Drug; C043482:moxonidine; D003000:Clonidine; D000077769:Rilmenidine
Imidazolrezeptoren und Blutdruckregulation. Hohe Rezeptorselektivität von Moxonidin.